Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hope for rapid equine influenza test
“Preventing a new influenza pandemic requires both vaccination and antiviral drugs to be administered within 48 hours of the infection."
Scientists say dipstick test could offer results in seconds 

A simple dipstick test could offer a rapid, non-invasive method of screening for equine influenza.

Iceni Diagnostics has a patent for its approach to detecting and distinguishing between human and avian flu. The company believes that with a slight modification, the test could be used for routine screening in horses before they travel to race meets and other gatherings.

Professor Robert Field, co-founder at Iceni, said 90 per cent of infections use carbohydrate recognition to bind with targets in humans and animals. This mechanism is specific to each strain of flu, so it can be used as a sensor for the disease.

“Our sensor uses sugars tagged with inexpensive gold nanoparticles,” he explained. “If the virus is present it will stick to the particles, pulling them closer together. This creates a photophysics reaction and the sample changes colour.

“We have found that there are differences between the carbohydrate detectors in the different types of flu. It is therefore possible to use a colour change to identify presence and absence of the virus and to distinguish between them.”

Using sugars instead of more commonly used protein-based diagnostics avoids the need for cold storage, meaning the test can be used worldwide with minimal training, and gives results in seconds.

According to Professor David Russell, chief scientist at Iceni, the new assay based on gold nanoparticles is much faster than current tests.

“Preventing a new influenza pandemic requires both vaccination and antiviral drugs to be administered within 48 hours of the infection in order to contain the disease,” he said.

“Current methods of detection require isolation and culturing of the virus, which may take several hours or even days to get the results. Using our test it would be possible to quickly identify infected animals at the stables and quarantine them, preventing the spread of disease.”

Iceni is now looking for investment to modify its sensor to produce a dip test for equine flu.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.